Gentian Diagnostics Balance Sheet Health
Financial Health criteria checks 6/6
Gentian Diagnostics has a total shareholder equity of NOK157.4M and total debt of NOK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NOK186.9M and NOK29.5M respectively. Gentian Diagnostics's EBIT is NOK2.5M making its interest coverage ratio -1.5. It has cash and short-term investments of NOK81.0M.
Key information
0%
Debt to equity ratio
NOK 0
Debt
| Interest coverage ratio | -1.5x |
| Cash | NOK 81.02m |
| Equity | NOK 157.38m |
| Total liabilities | NOK 29.49m |
| Total assets | NOK 186.86m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6FK's short term assets (NOK145.8M) exceed its short term liabilities (NOK21.6M).
Long Term Liabilities: 6FK's short term assets (NOK145.8M) exceed its long term liabilities (NOK7.8M).
Debt to Equity History and Analysis
Debt Level: 6FK is debt free.
Reducing Debt: 6FK has no debt compared to 5 years ago when its debt to equity ratio was 0.3%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 6FK has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 6FK is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 13.6% per year.